Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of SEP-363856 in Subjects with Parkinson's Disease Psychosis
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Sunovion Pharmaceuticals, Inc
Start Date
March 22, 2017
End Date
March 5, 2019
Administered By
Neurology, Movement Disorders
Awarded By
Sunovion Pharmaceuticals, Inc
Start Date
March 22, 2017
End Date
March 5, 2019